Institutional investors purchased a net $6.6 million shares of IMMU during the quarter ended June 2014, and now own 41.92% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CREATIVE PLANNING, INC. Bought 1.0 Thousand shares of Immunomedics Inc
SATUIT FUNDS MANAGEMENT LLC Bought 755.00 shares of Immunomedics Inc